Literature DB >> 29340760

Infections associated with ruxolitinib: study in the French Pharmacovigilance database.

Pinel Sylvine1, Sternjacob Thomas2, Eftekhari Pirayeh2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29340760     DOI: 10.1007/s00277-018-3242-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  6 in total

1.  Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis.

Authors:  Douglas Tremblay; Amber King; Lihua Li; Erin Moshier; Alexander Coltoff; Anita Koshy; Marina Kremyanskaya; Ronald Hoffman; Michael J Mauro; Raajit K Rampal; John Mascarenhas
Journal:  Leuk Lymphoma       Date:  2019-11-12

Review 2.  Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review.

Authors:  Naruemit Sayabovorn; Piriyaporn Chongtrakool; Methee Chayakulkeeree
Journal:  BMC Infect Dis       Date:  2021-01-07       Impact factor: 3.090

Review 3.  Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors.

Authors:  Daniele Cattaneo; Alessandra Iurlo
Journal:  Front Immunol       Date:  2021-11-19       Impact factor: 7.561

4.  Disseminated Mycobacterium avium Complex Myositis in a Patient With Graft-Versus-Host Disease.

Authors:  Kathryn Grace Kompa; Caitlin A Trottier; Charles L Hyman; Rakhi Kohli
Journal:  Open Forum Infect Dis       Date:  2022-07-29       Impact factor: 4.423

5.  Frequent Klebsiella pneumoniae Urinary Tract Infections in a Patient Treated with Ruxolitinib.

Authors:  Ramy M Hanna; Maham Khalid; Lama Abd El-Nour; Umut Selamet
Journal:  Antibiotics (Basel)       Date:  2019-09-16

Review 6.  Invasive Fungal Infections and Targeted Therapies in Hematological Malignancies.

Authors:  Jessica S Little; Zoe F Weiss; Sarah P Hammond
Journal:  J Fungi (Basel)       Date:  2021-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.